135 related articles for article (PubMed ID: 11438529)
1. Definition of the extended substrate specificity determinants for beta-tryptases I and II.
Harris JL; Niles A; Burdick K; Maffitt M; Backes BJ; Ellman JA; Kuntz I; Haak-Frendscho M; Craik CS
J Biol Chem; 2001 Sep; 276(37):34941-7. PubMed ID: 11438529
[TBL] [Abstract][Full Text] [Related]
2. Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft.
Huang C; Li L; Krilis SA; Chanasyk K; Tang Y; Li Z; Hunt JE; Stevens RL
J Biol Chem; 1999 Jul; 274(28):19670-6. PubMed ID: 10391906
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase.
Hallgren J; Lindahl S; Pejler G
J Mol Biol; 2005 Jan; 345(1):129-39. PubMed ID: 15567416
[TBL] [Abstract][Full Text] [Related]
4. Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B.
Mahrus S; Kisiel W; Craik CS
J Biol Chem; 2004 Dec; 279(52):54275-82. PubMed ID: 15494398
[TBL] [Abstract][Full Text] [Related]
5. Definition and redesign of the extended substrate specificity of granzyme B.
Harris JL; Peterson EP; Hudig D; Thornberry NA; Craik CS
J Biol Chem; 1998 Oct; 273(42):27364-73. PubMed ID: 9765264
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of prostasin, a channel activating protease.
Shipway A; Danahay H; Williams JA; Tully DC; Backes BJ; Harris JL
Biochem Biophys Res Commun; 2004 Nov; 324(2):953-63. PubMed ID: 15474520
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of recombinant gamma-tryptase.
Yuan J; Beltman J; Gjerstad E; Nguyen MT; Sampang J; Chan H; Janc JW; Clark JM
Protein Expr Purif; 2006 Sep; 49(1):47-54. PubMed ID: 16815034
[TBL] [Abstract][Full Text] [Related]
8. Importance of the P4' residue in human granzyme B inhibitors and substrates revealed by scanning mutagenesis of the proteinase inhibitor 9 reactive center loop.
Sun J; Whisstock JC; Harriott P; Walker B; Novak A; Thompson PE; Smith AI; Bird PI
J Biol Chem; 2001 May; 276(18):15177-84. PubMed ID: 11278311
[TBL] [Abstract][Full Text] [Related]
9. Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries.
Li J; Lim SP; Beer D; Patel V; Wen D; Tumanut C; Tully DC; Williams JA; Jiricek J; Priestle JP; Harris JL; Vasudevan SG
J Biol Chem; 2005 Aug; 280(31):28766-74. PubMed ID: 15932883
[TBL] [Abstract][Full Text] [Related]
10. Characterization of structural determinants of granzyme B reveals potent mediators of extended substrate specificity.
Ruggles SW; Fletterick RJ; Craik CS
J Biol Chem; 2004 Jul; 279(29):30751-9. PubMed ID: 15123647
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and physical characterization of a P1 arginine combinatorial library, and its application to the determination of the substrate specificity of serine peptidases.
Furlong ST; Mauger RC; Strimpler AM; Liu YP; Morris FX; Edwards PD
Bioorg Med Chem; 2002 Nov; 10(11):3637-47. PubMed ID: 12213480
[TBL] [Abstract][Full Text] [Related]
12. The crystal structure of human alpha1-tryptase reveals a blocked substrate-binding region.
Marquardt U; Zettl F; Huber R; Bode W; Sommerhoff C
J Mol Biol; 2002 Aug; 321(3):491-502. PubMed ID: 12162961
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers.
Herter S; Piper DE; Aaron W; Gabriele T; Cutler G; Cao P; Bhatt AS; Choe Y; Craik CS; Walker N; Meininger D; Hoey T; Austin RJ
Biochem J; 2005 Aug; 390(Pt 1):125-36. PubMed ID: 15839837
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families.
Caughey GH; Raymond WW; Blount JL; Hau LW; Pallaoro M; Wolters PJ; Verghese GM
J Immunol; 2000 Jun; 164(12):6566-75. PubMed ID: 10843716
[TBL] [Abstract][Full Text] [Related]
15. Human tryptase epsilon (PRSS22), a new member of the chromosome 16p13.3 family of human serine proteases expressed in airway epithelial cells.
Wong GW; Yasuda S; Madhusudhan MS; Li L; Yang Y; Krilis SA; Sali A; Stevens RL
J Biol Chem; 2001 Dec; 276(52):49169-82. PubMed ID: 11602603
[TBL] [Abstract][Full Text] [Related]
16. X-ray structures of free and leupeptin-complexed human alphaI-tryptase mutants: indication for an alpha-->beta-tryptase transition.
Rohr KB; Selwood T; Marquardt U; Huber R; Schechter NM; Bode W; Than ME
J Mol Biol; 2006 Mar; 357(1):195-209. PubMed ID: 16414069
[TBL] [Abstract][Full Text] [Related]
17. Mammalian tissue trypsin-like enzymes: substrate specificity and inhibitory potency of substituted isocoumarin mechanism-based inhibitors, benzamidine derivatives, and arginine fluoroalkyl ketone transition-state inhibitors.
Kam CM; Hernandez MA; Patil GS; Ueda T; Simmons WH; Braganza VJ; Powers JC
Arch Biochem Biophys; 1995 Feb; 316(2):808-14. PubMed ID: 7864637
[TBL] [Abstract][Full Text] [Related]
18. Bivalent inhibition of human beta-tryptase.
Schaschke N; Matschiner G; Zettl F; Marquardt U; Bergner A; Bode W; Sommerhoff CP; Moroder L
Chem Biol; 2001 Apr; 8(4):313-27. PubMed ID: 11325588
[TBL] [Abstract][Full Text] [Related]
19. The arginine mimicking β-amino acid β³hPhe(3-H₂N-CH₂) as S1 ligand in cyclotheonamide-based β-tryptase inhibitors.
Janke D; Sommerhoff CP; Schaschke N
Bioorg Med Chem; 2011 Dec; 19(23):7236-43. PubMed ID: 22047802
[TBL] [Abstract][Full Text] [Related]
20. The human mast cell tryptase tetramer: a fascinating riddle solved by structure.
Sommerhoff CP; Bode W; Matschiner G; Bergner A; Fritz H
Biochim Biophys Acta; 2000 Mar; 1477(1-2):75-89. PubMed ID: 10708850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
